Optimizing high dimensional gene expression studies for immune response following smallpox vaccination using Taqman® Low density immune arrays

Journal of Immunological Methods

Volumn 366, Issue 1-2, 2011, Pages 69-78

  Oberg, Ann L ^a   Dhiman, Neelam ^a   Grill, Diane E ^a   Ryan, Jenna E ^a   Kennedy, Richard B ^a   Poland, Gregory A ^a  

^a MAYO CLINIC   (United States)

Author keywords

Microarray; Smallpox; TLDA; Vaccinia virus

Indexed keywords

CYTOKINE; SMALLPOX VACCINE;

ADULT; ARTICLE; CYTOKINE RELEASE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNE RESPONSE; IMMUNE RESPONSE GENE; LOW DENSITY IMMUNE ARRAY; MALE; MICROARRAY ANALYSIS; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; VACCINIA; VACCINIA VIRUS;

ADOLESCENT; ADULT; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; GENE EXPRESSION PROFILING; GENES, MHC CLASS II; HUMANS; LEUKOCYTES, MONONUCLEAR; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMERASE CHAIN REACTION; SMALLPOX VACCINE; VACCINIA VIRUS; YOUNG ADULT;

VACCINIA VIRUS; VARIOLA VIRUS;

EID: 79952316511     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2011.01.011     Document Type: Article

References (53)

1. Abruzzo L.V., Wang J., Kapoor M., Medeiros L.J., Keating M.J., Edward H.W., Barron L.L., Cromwell C.C., Coombes K.R. Biological validation of differentially expressed genes in chronic lymphocytic leukemia identified by applying multiple statistical methods to oligonucleotide microarrays. J. Mol. Diagn. 2005, 7:337.
2. Albertson D.G., Pinkel D. Genomic microarrays in human genetic disease and cancer. Hum. Mol. Genet. 2003, 12(Spec No 2):R145.
3. Assarsson E., Greenbaum J.A., Sundstrom M., Schaffer L., Hammond J.A., Pasquetto V., Oseroff C., Hendrickson R.C., Lefkowitz E.J., Tscharke D.C., Sidney J., Grey H.M., Head S.R., Peters B., Sette A. Kinetic analysis of a complete poxvirus transcriptome reveals an immediate-early class of genes. Proc. Natl Acad. Sci. USA 2008, 105:2140.
4. Baron C., Somogyi R., Greller L.D., Rineau V., Wilkinson P., Cho C.R., Cameron M.J., Kelvin D.J., Chagnon P., Roy D.C., Busque L., Sekaly R.P., Perreault C. Prediction of graft-versus-host disease in humans by donor gene-expression profiling. PLoS Med. 2007, 4:e23.
5. Bland J.M., Altman D.G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986, 1:307.
6. Bolstad B.M., Irizarry R.A., Astrand M., Speed T.P. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003, 19:185.
7. Buller R.M., Palumbo G.J. Poxvirus pathogenesis. Microbiol. Rev. 1991, 55:80.
8. Chen S., Wilson D.B. Proteomic and transcriptomic analysis of extracellular proteins and mRNA levels in Thermobifida fusca grown on cellobiose and glucose. J. Bacteriol. 2007, 189:6260.
9. Cunningham J.M., Oberg A.L., Borralho P.M., Kren B.T., French A.J., Wang L., Bot B.M., Morlan B.W., Silverstein K.A., Staggs R., Zeng Y., Lamblin A.F., Hilker C.A., Fan J.B., Steer C.J., Thibodeau S.N. Evaluation of a new high-dimensional miRNA profiling platform. BMC Med. Genomics 2009, 2:57.
10. Dhiman N., Bonilla R., O'Kane D., Poland G.A. Gene expression microarrays: a 21st century tool for directed vaccine design. Vaccine 2002, 20:22.
11. Dhiman N., Ovsyannikova I.G., Howe R.C., Ryan J.E., Jacobson R.M., Poland G.A. Interleukin-4 induced by measles virus and measles-derived peptides as measured by IL-4 receptor-blocking ELISA. J. Immunol. Meth. 2004, 287:217.
12. Dudoit S., Yang Y.H., Callow M.J., Speed T.P. Statistical methods for identifying genes with differential expression in replicated cDNA microarray experiments. Stat. Sin. 2002, 12:111.
13. Earl P.L., Cooper N., Wyatt L.S., Moss B., Carroll M.W. Preparation of cell cultures and vaccinia virus stocks. Curr. Protoc. Mol. Biol. 2001, Chapter 16, Unit16.
14. Earl P.L., Moss B., Wyatt L.S., Carroll M.W. Generation of recombinant vaccinia viruses. Curr. Protoc. Mol. Biol. 2001, Chapter 16, Unit16.
15. Eckel J.E., Gennings C., Therneau T.M., Burgoon L.D., Boverhof D.R., Zacharewski T.R. Normalization of two-channel microarray experiments: a semiparametric approach. Bioinformatics 2005, 21:1078.
16. Ennis F.A., Cruz J., Demkowicz W.E., Rothman A.L., McClain D.J. Primary induction of human CD8+ cytotoxic T lymphocytes and interferon-producing T cells after smallpox vaccination. J. Infect. Dis. 2002, 185:1657.
17. Esteves G.H., Simoes A.C., Souza E., Dias R.A., Ospina R., Venancio T.M. New insights about host response to smallpox using microarray data. BMC Syst. Biol. 2007, 1:38.
18. Fagan A., Culhane A.C., Higgins D.G. A multivariate analysis approach to the integration of proteomic and gene expression data. Proteomics 2007, 7:2162.
19. Friebe A., Siegling A., Friederichs S., Volk H.D., Weber O. Immunomodulatory effects of inactivated parapoxvirus ovis (ORF virus) on human peripheral immune cells: induction of cytokine secretion in monocytes and Th1-like cells. J. Virol. 2004, 78:9400.
20. Grinde B., Gayorfar M., Hoddevik G. Modulation of gene expression in a human cell line caused by poliovirus, vaccinia virus and interferon. Virol. J. 2007, 4:24.
21. Guerra S., L¢pez-Fern ndez L.A., Pascual-Montano A., Munoz M., Harshman K., Esteban M. Cellular gene expression survey of vaccinia virus infection of human HeLa cells. J. Virol. 2003, 77:6493.
22. Guerra S., Lopez-Fernandez L.A., Conde R., Pascual-Montano A., Harshman K., Esteban M. Microarray analysis reveals characteristic changes of host cell gene expression in response to attenuated modified vaccinia virus Ankara infection of human HeLa cells. J. Virol. 2004, 78:5820.
23. Guerra S., Najera J.L., Gonzalez J.M., Lopez-Fernandez L.A., Climent N., Gatell J.M., Gallart T., Esteban M. Distinct gene expression profiling after infection of immature human monocyte-derived dendritic cells by the attenuated poxvirus vectors MVA and NYVAC. J. Virol. 2007, 81:8707.
24. Gygi S.P., Rochon Y., Franza B.R., Aebersold R. Correlation between protein and mRNA abundance in yeast. Mol. Cell. Biol. 1999, 19:1720.
25. Heidecker B., Hare J.M. The use of transcriptomic biomarkers for personalized medicine. Heart Fail. Rev. 2007, 12:1.
26. Hershko A., Ciechanover A. The ubiquitin system. Annu. Rev. Biochem. 1998, 67:425.
27. Jain K.K. Personalised medicine for cancer: from drug development into clinical practice. Expert Opin. Pharmacother. 2005, 6:1463.
28. Jungwirth C., Launer J. Effect of poxvirus infection on host cell deoxyribonucleic acid synthesis. J. Virol. 1968, 2:401.
29. Kagedal B., Farneback M., Hakansson A., Gustafsson B., Hakansson L. How useful are housekeeping genes? Variable expression in melanoma metastases. Clin. Chem. Lab. Med. 2007, 45:1481.
30. Kennedy R., Pankratz V.S., Swanson E., Watson D., Golding H., Poland G.A. Statistical approach to estimate vaccinia-specific neutralizing antibody titers using a high throughput assay. Clin. Vaccine Immunol. 2009, 16:1105.
31. KIT S., DUBBS D.R. Biochemistry of vaccinia-infected mouse fibroblasts (strain L-M). IV. 3H-thymidine uptake into DNA of cells exposed to cold shock. Exp. Cell Res. 1963, 31:397.
32. Kodadek T. No splicing, no dicing: non-proteolytic roles of the ubiquitin-proteasome system in transcription. J. Biol. Chem. 2010, 285:2221.
33. Kriegova E., Arakelyan A., Fillerova R., Zatloukal J., Mrazek F., Navratilova Z., Kolek V., du Bois R.M., Petrek M. PSMB2 and RPL32 are suitable denominators to normalize gene expression profiles in bronchoalveolar cells. BMC Mol. Biol. 2008, 9:69.
34. Manischewitz J., King L.R., Bleckwenn N.A., Shiloach J., Taffs R., Merchlinsky M., Eller N., Mikolajczyk M.G., Clanton D.J., Monath T., Weltzin R.A., Scott D.E., Golding H. Development of a novel vaccinia-neutralization assay based on reporter-gene expression. J. Infect. Dis. 2003, 188:440.
35. Marco M.L., Kleerebezem M. Assessment of real-time RT-PCR for quantification of Lactobacillus plantarum gene expression during stationary phase and nutrient starvation. J. Appl. Microbiol. 2008, 104:587.
36. Maynard J.A., Myhre R., Roy B. Microarrays in infection and immunity. Curr. Opin. Chem. Biol. 2007, 11:306.
37. Morley M., Molony C.M., Weber T.M., Devlin J.L., Ewens K.G., Spielman R.S., Cheung V.G. Genetic analysis of genome-wide variation in human gene expression. Nature 2004, 430:743.
38. Moutaftsi M., Tscharke D.C., Vaughan K., Koelle D.M., Stern L., Calvo-Calle M., Ennis F., Terajima M., Sutter G., Crotty S., Drexler I., Franchini G., Yewdell J.W., Head S.R., Blum J., Peters B., Sette A. Uncovering the interplay between CD8, CD4 and antibody responses to complex pathogens. Future Microbiol. 2010, 5:221.
39. Neuman de Vegvar H.E., Robinson W.H. Microarray profiling of antiviral antibodies for the development of diagnostics, vaccines, and therapeutics. Clin. Immunol. 2004, 111:196.
40. Newman F.K., Frey S.E., Blevins T.P., Mandava M., Bonifacio A., Yan L., Belshe R.B. Improved assay to detect neutralizing antibody following vaccination with diluted or undiluted vaccinia (Dryvax) vaccine. J. Clin. Microbiol. 2003, 41:3154.
41. Oberg A.L., Mahoney D.W., Ballman K.V., Therneau T.M. Joint estimation of calibration and expression for high-density oligonucleotide arrays. Bioinformatics 2006, 22:2381.
42. Ovsyannikova I.G., Jacobson R.M., Ryan J.E., Vierkant R.A., Pankratz V.S., Jacobsen S.J., Poland G.A. HLA class II alleles and measles virus-specific cytokine immune response following two doses of measles vaccine. Immunogenetics 2005, 56:798.
43. Ovsyannikova I.G., Ryan J.E., Vierkant R.A., Pankratz S.V., Jacobson R.M., Poland G.A. Immunologic significance of HLA class I genes in measles virus-specific IFN-gamma and IL-4 cytokine immune responses. Immunogenetics 2005, 57:828.
44. Rubins K.H., Hensley L.E., Jahrling P.B., Whitney A.R., Geisbert T.W., Huggins J.W., Owen A., LeDuc J.W., Brown P.O., Relman D.A. The host response to smallpox: analysis of the gene expression program in peripheral blood cells in a nonhuman primate model. Proc. Nat. Acad. Sci. U.S.A. 2004, 101:15190.
45. Ryan J.E., Dhiman N., Ovsyannikova I.G., Vierkant R.A., Pankratz V.S., Poland G.A. Response surface methodology to determine optimal cytokine responses in human peripheral blood mononuclear cells after smallpox vaccination. J. Immunol. Meth. 2009, 341:97.
46. Scherer C.A., Magness C.L., Steiger K.V., Poitinger N.D., Caputo C.M., Miner D.G., Winokur P.L., Klinzman D., McKee J., Pilar C., Ward P.A., Gillham M.H., Haulman N.J., Stapleton J.T., Iadonato S.P. Distinct gene expression profiles in peripheral blood mononuclear cells from patients infected with vaccinia virus, yellow fever 17D virus, or upper respiratory infections. Vaccine 2007, 25:6458.
47. Steibel J.P., Poletto R., Coussens P.M., Rosa G.J. A powerful and flexible linear mixed model framework for the analysis of relative quantification RT-PCR data. Genomics 2009, 94:146.
48. Trevino V., Falciani F., Barrera-Saldana H.A. DNA microarrays: a powerful genomic tool for biomedical and clinical research. Mol. Med. 2007, 13:527.
49. Tsung K., Yim J.H., Marti W., Buller R.M., Norton J.A. Gene expression and cytopathic effect of vaccinia virus inactivated by psoralen and long-wave UV light. J. Virol. 1996, 70:165.
50. Valdivia-Granda W.A., Kann M.G., Malaga J. Transcriptional interactions during smallpox infection and identification of early infection biomarkers. Pac. Symp. Biocomput. 2007, 100.
51. Watson S.J., Meng F., Thompson R.C., Akil H. The "chip" as a specific genetic tool. Soc. Biol. Psychiatry 2000, 48:1147.
52. Zhang Z., Abrahams M.R., Hunt L.A., Suttles J., Marshall W., Lahiri D.K., Kotwal G.J. The vaccinia virus N1L protein influences cytokine secretion in vitro after infection. Ann. NY Acad. Sci. 2005, 1056:69.
53. Zhang W., Li F., Nie L. Integrating multiple 'omics' analysis for microbial biology: application and methodologies. Microbiology 2010, 156:287.